1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine has been researched along with zalcitabine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barchi, JJ; Driscoll, JS; Kelley, JA; Marquez, VE; Mitsuya, H; Roth, JS; Shirasaka, T; Siddiqui, MA | 1 |
| Cheng, LC; Chou, TC; Fox, JJ; Harada, K; Matulic-Adamic, J; Ren, WY; Takahashi, K; Watanabe, KA; Zeidler, J; Zhu, QY | 1 |
| Bushnell, DJ; Duncan, IB; Dunsdon, SJ; Hall, MJ; Machin, PJ; Martin, JA; Merrett, JH; Parkes, KE; Roberts, NA; Thomas, GJ | 1 |
| Brankovan, V; Ghazzouli, I; Mansuri, MM; Martin, JC; Sterzycki, RZ | 1 |
| Antonenko, SV; Chentsova, NP; Kukhar, VP; Luik, AI; Poda, GI; Tetko, IV | 1 |
| Edelman, K; Hooker, M; Muirhead, GJ; Rousseau, FS; Sereni, D; Williams, PE | 1 |
1 trial(s) available for 1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine and zalcitabine
| Article | Year |
|---|---|
Pharmacokinetics of 2-fluorodideoxycytidine (2FddC) in patients infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antiviral Agents; Biological Availability; Drug Administration Schedule; HIV Infections; Humans; Injections, Intravenous; Male; Middle Aged; Zalcitabine | 1993 |
5 other study(ies) available for 1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine and zalcitabine
| Article | Year |
|---|---|
Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Chemical Phenomena; Chemistry, Physical; Cytarabine; Cytidine Deaminase; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Stability; HIV-1; Hydrogen-Ion Concentration; Macaca mulatta; Molecular Structure; Structure-Activity Relationship; Zalcitabine | 1992 |
Synthesis and anti-HIV-1 activity of 2'-"up"-fluoro analogues of active anti-AIDS nucleosides 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (DDC).
Topics: Antiviral Agents; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; HIV Antigens; HIV-1; Humans; Molecular Structure; RNA-Directed DNA Polymerase; Zalcitabine; Zidovudine | 1990 |
Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1).
Topics: Antiviral Agents; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Deoxyribonucleosides; Dideoxynucleosides; Fluorine; HIV-1; Humans; Lymphocytes; Molecular Structure; Pyrimidine Nucleosides; Structure-Activity Relationship; Zalcitabine | 1990 |
Synthesis and anti-HIV activity of several 2'-fluoro-containing pyrimidine nucleosides.
Topics: Antineoplastic Agents; Antiviral Agents; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Fluorine; Gene Products, gag; HIV; HIV Antigens; HIV Core Protein p24; Humans; Macrophages; Molecular Structure; Monocytes; Pyrimidine Nucleosides; T-Lymphocytes; Tumor Cells, Cultured; Viral Core Proteins; Zalcitabine; Zidovudine | 1990 |
HIV-1 reverse transcriptase inhibitor design using artificial neural networks.
Topics: Algorithms; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Neural Networks, Computer; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; T-Lymphocytes; Zidovudine | 1994 |